Literature DB >> 30359112

Estimated Prevalence of Opioid Use Disorder in Massachusetts, 2011-2015: A Capture-Recapture Analysis.

Joshua A Barocas1, Laura F White1, Jianing Wang1, Alexander Y Walley1, Marc R LaRochelle1, Dana Bernson1, Thomas Land1, Jake R Morgan1, Jeffrey H Samet1, Benjamin P Linas1.   

Abstract

OBJECTIVES: To estimate the annual prevalence of opioid use disorder (OUD) in Massachusetts from 2011 to 2015.
METHODS: We performed a multisample stratified capture-recapture analysis to estimate OUD prevalence in Massachusetts. Individuals identified from 6 administrative databases for 2011 to 2012 and 7 databases for 2013 to 2015 were linked at the individual level and included in the analysis. Individuals were stratified by age group, sex, and county of residence.
RESULTS: The OUD prevalence in Massachusetts among people aged 11 years or older was 2.72% in 2011 and 2.87% in 2012. Between 2013 and 2015, the prevalence increased from 3.87% to 4.60%. The greatest increase in prevalence was observed among those in the youngest age group (11-25 years), a 76% increase from 2011 to 2012 and a 42% increase from 2013 to 2015.
CONCLUSIONS: In Massachusetts, the OUD prevalence was 4.6% among people 11 years or older in 2015. The number of individuals with OUD is likely increasing, particularly among young people.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30359112      PMCID: PMC6236756          DOI: 10.2105/AJPH.2018.304673

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   11.561


  22 in total

1.  Underreporting of illicit drug use by patients at emergency departments as revealed by two-tiered urinalysis.

Authors:  Wei J Chen; Cheng-Chung Fang; Ren-Shi Shyu; Kuo-Chien Lin
Journal:  Addict Behav       Date:  2006-03-29       Impact factor: 3.913

2.  Massachusetts's experience suggests coverage alone is insufficient to increase addiction disorders treatment.

Authors:  Victor A Capoccia; Kyle L Grazier; Christopher Toal; James H Ford; David H Gustafson
Journal:  Health Aff (Millwood)       Date:  2012-05       Impact factor: 6.301

3.  Using Population Based Hospitalization Data to Monitor Increases in Conditions Causing Morbidity Among Persons Who Inject Drugs.

Authors:  Melissa G Collier; Mona Doshani; Alice Asher
Journal:  J Community Health       Date:  2018-06

4.  Injection drug use and overdose among young adults who use prescription opioids non-medically.

Authors:  Elliott J Liebling; Traci C Green; Scott E Hadland; Brandon D L Marshall
Journal:  Addict Behav       Date:  2017-07-18       Impact factor: 3.913

5.  Defining problematic pharmaceutical opioid use among people prescribed opioids for chronic noncancer pain: do different measures identify the same patients?

Authors:  Gabrielle Campbell; Raimondo Bruno; Nicholas Lintzeris; Milton Cohen; Suzanne Nielsen; Wayne Hall; Briony Larance; Richard P Mattick; Fiona Blyth; Michael Farrell; Louisa Degenhardt
Journal:  Pain       Date:  2016-07       Impact factor: 6.961

6.  Capture-recapture: a useful methodological tool for counting traffic related injuries?

Authors:  A Morrison; D H Stone
Journal:  Inj Prev       Date:  2000-12       Impact factor: 2.399

7.  US regional and demographic differences in prescription opioid and heroin-related overdose hospitalizations.

Authors:  George Jay Unick; Daniel Ciccarone
Journal:  Int J Drug Policy       Date:  2017-07-05

8.  Looking for the uninsured in Massachusetts? Check opioid dependent persons seeking detoxification.

Authors:  M D Stein; G L Bailey; P Thurmond; N Paull
Journal:  Drug Alcohol Depend       Date:  2014-01-03       Impact factor: 4.492

9.  Capture-recapture estimates of problem drug use and the use of simulation based confidence intervals in a stratified analysis.

Authors:  Islay Gemmell; Tim Millar; Gordon Hay
Journal:  J Epidemiol Community Health       Date:  2004-09       Impact factor: 3.710

10.  Characteristics of Fentanyl Overdose - Massachusetts, 2014-2016.

Authors:  Nicholas J Somerville; Julie O'Donnell; R Matthew Gladden; Jon E Zibbell; Traci C Green; Morgan Younkin; Sarah Ruiz; Hermik Babakhanlou-Chase; Miranda Chan; Barry P Callis; Janet Kuramoto-Crawford; Henry M Nields; Alexander Y Walley
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-04-14       Impact factor: 17.586

View more
  41 in total

1.  The True Prevalence of Opioid Use Disorder Nationally Is Likely Underestimated.

Authors:  Monica Bharel
Journal:  Am J Public Health       Date:  2019-02       Impact factor: 9.308

2.  Estimating the Number of People Who Inject Drugs in A Rural County in Appalachia.

Authors:  Sean T Allen; Allison O'Rourke; Rebecca Hamilton White; Kristin E Schneider; Michael Kilkenny; Susan G Sherman
Journal:  Am J Public Health       Date:  2019-01-24       Impact factor: 9.308

3.  Maternal and infant characteristics associated with maternal opioid overdose in the year following delivery.

Authors:  Timothy Nielsen; Dana Bernson; Mishka Terplan; Sarah E Wakeman; Amy M Yule; Pooja K Mehta; Monica Bharel; Hafsatou Diop; Elsie M Taveras; Timothy E Wilens; Davida M Schiff
Journal:  Addiction       Date:  2019-11-13       Impact factor: 6.526

Review 4.  Opioid use disorder.

Authors:  John Strang; Nora D Volkow; Louisa Degenhardt; Matthew Hickman; Kimberly Johnson; George F Koob; Brandon D L Marshall; Mark Tyndall; Sharon L Walsh
Journal:  Nat Rev Dis Primers       Date:  2020-01-09       Impact factor: 52.329

5.  Opioid and Substance Use Disorder and Receipt of Treatment Among Parents Living With Children in the United States, 2015-2017.

Authors:  Lisa Clemans-Cope; Victoria Lynch; Marni Epstein; Genevieve M Kenney
Journal:  Ann Fam Med       Date:  2019-05       Impact factor: 5.166

6.  Methodological Challenges and Proposed Solutions for Evaluating Opioid Policy Effectiveness.

Authors:  Megan S Schuler; Beth Ann Griffin; Magdalena Cerdá; Emma E McGinty; Elizabeth A Stuart
Journal:  Health Serv Outcomes Res Methodol       Date:  2020-11-12

7.  Which patients receive an addiction consult? A preliminary analysis of the INREACH (INpatient REadmission post-Addiction Consult Help) study.

Authors:  Maria J D'Amico; Alexander Y Walley; Debbie M Cheng; Leah S Forman; Danny Regan; Alexandra Yurkovic; Jeffrey H Samet; Zoe M Weinstein
Journal:  J Subst Abuse Treat       Date:  2019-08-20

8.  Patterns, contexts, and motivations for polysubstance use among people who inject drugs in non-urban settings in the U.S. Northeast.

Authors:  Pablo K Valente; Angela R Bazzi; Ellen Childs; Peter Salhaney; Joel Earlywine; Jennifer Olson; Dea L Biancarelli; Brandon D L Marshall; Katie B Biello
Journal:  Int J Drug Policy       Date:  2020-09-07

9.  Hospitalization outcomes of people who use drugs: One size does not fit all.

Authors:  Elisabeth Merchant; Deirdre Burke; Leah Shaw; Hansel Tookes; Dustin Patil; Joshua A Barocas; Alysse G Wurcel
Journal:  J Subst Abuse Treat       Date:  2020-01-22

10.  Documented opioid use disorder and its treatment in primary care patients across six U.S. health systems.

Authors:  Denise M Boudreau; Gwen Lapham; Eric A Johnson; Jennifer F Bobb; Abigail G Matthews; Jennifer McCormack; David Liu; Cynthia I Campbell; Rebecca C Rossom; Ingrid A Binswanger; Bobbi Jo Yarborough; Julia H Arnsten; Chinazo O Cunningham; Joseph E Glass; Mark T Murphy; Mohammad Zare; Rulin C Hechter; Brian Ahmedani; Jordan M Braciszewski; Viviana E Horigian; José Szapocznik; Jeffrey H Samet; Andrew J Saxon; Robert P Schwartz; Katharine A Bradley
Journal:  J Subst Abuse Treat       Date:  2020-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.